AtriCure
ATRC
211 hedge funds and large institutions have $1.99B invested in AtriCure in 2022 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 74 increasing their positions, 79 reducing their positions, and 26 closing their positions.
22% more call options, than puts
Call options by funds: $1.63M | Put options by funds: $1.33M
14% more capital invested
Capital invested by funds: $1.74B → $1.99B (+$250M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 26
0.65% less ownership
Funds ownership: 96.16% → 95.52% (-0.65%)
1% less funds holding
Funds holding: 213 → 211 (-2)
6% less repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 79
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$55.2M |
| 2 |
Millennium Management
New York
|
+$31.3M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$8.35M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$6.76M |
| 5 |
BlackRock
New York
|
+$6.36M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAM
Fred Alger Management
New York
|
-$23.9M |
| 2 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$23.2M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
-$20.2M |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$9.07M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$7.1M |
ATRC Hedge Fund Activity: Q4 2022 in Review
211 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q4 2022, worth a combined $1.99B — up 14% from $1.74B a quarter earlier.
Fund positioning in ATRC was balanced in Q4 2022: 26 funds opened new positions, 26 closed out, 74 added to existing stakes and 79 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $55.2M. The largest seller was Fred Alger Management, cutting an estimated $23.9M.
- 211 institutional investors held AtriCure (ATRC) as of Q4 2022, down from 213 in Q3 2022.
- Funds reported $1.99B of AtriCure stock for Q4 2022, up 14% quarter-over-quarter.
- 26 funds opened new AtriCure positions in Q4 2022 and 26 closed out, a net change of 0 holders.
- The largest AtriCure buyer in Q4 2022 was Wellington Management Group, an estimated $55.2M added.
- The largest AtriCure seller in Q4 2022 was Fred Alger Management, an estimated $23.9M sold.
Based on aggregated 13F filings for Q4 2022.